诺诚健华(688428)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688428 诺诚健华

已收盘 04-30 15:00:00

{"stockData":{"symbol":"688428","market":"SH","secType":"STK","nameCN":"诺诚健华","latestPrice":8.66,"timestamp":1714460400000,"preClose":8.55,"halted":0,"volume":3273792,"delay":0,"floatShares":256999999,"shares":1763000000,"eps":-0.2133,"marketStatus":"已收盘","marketStatusCode":5,"change":0.11,"latestTime":"04-30 15:00:00","open":8.51,"high":8.7,"low":8.5,"amount":28141800,"amplitude":0.0234,"askPrice":8.67,"askSize":157,"bidPrice":8.66,"bidSize":53,"shortable":0,"etf":0,"ttmEps":-0.2133,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1714959000000},"adr":0,"adjPreClose":8.55,"symbolType":"stock_kcb","openAndCloseTimeList":[[1714440600000,1714447800000],[1714453200000,1714460400000]],"highLimit":9.41,"lowLimit":7.7,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":1762582452,"pbRate":2.14,"roa":"--","roe":"--","epsLYR":-0.37,"committee":-0.60479,"marketValue":15264000000,"floatMarketCap":2223000000,"peRate":-40.600093,"changeRate":0.0129,"turnoverRate":0.0128,"status":0,"afterMarket":{"amount":0,"volume":0,"close":8.66,"buyVolume":0,"sellVolume":0,"time":1714462439505,"indexStatus":"已收盘 04-30 15:30:00","preClose":8.55}},"requestUrl":"/m/hq/s/688428","defaultTab":"news","newsList":[{"id":"2432644950","title":"诺诚健华(09969)股价显著上升14.471%，现价港币$5.3","url":"https://stock-news.laohu8.com/highlight/detail?id=2432644950","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2432644950?lang=zh_cn&edition=full","pubTime":"2024-05-02 15:09","pubTimestamp":1714633740,"startTime":"0","endTime":"0","summary":"[上升股]诺诚健华(09969) 股价在下午03:09比前收市价显著上升14.471%，现股价为港币$5.3。至目前为止，今日最高价为$5.3，而最低价为$4.56。总成交量为170.472万股，总成交金额为港币$865.942万。","market":"sh","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2405024725/aamm-all-category","is_publish_highlight":false,"gpt_icon":0},{"id":"2432769493","title":"诺诚健华盘中异动 早盘快速上涨5.40%报4.880港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2432769493","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2432769493?lang=zh_cn&edition=full","pubTime":"2024-05-02 10:44","pubTimestamp":1714617848,"startTime":"0","endTime":"0","summary":"2024年05月02日早盘10时44分，诺诚健华股票出现异动，股价大幅上涨5.40%。截至发稿，该股报4.880港元/股，成交量27.4721万股，换手率0.02%，振幅6.91%。诺诚健华股票所在的生物技术行业中，整体涨幅为0.56%。消息层面，截至10时44分，《太平洋：给予诺诚健华买入评级，目标价位16.1元》资讯为影响诺诚健华的重要信息。首次覆盖给予“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502104409861eaa27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240502104409861eaa27&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2432369466","title":"诺诚健华(09969)上涨5.4%，报4.88元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2432369466","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2432369466?lang=zh_cn&edition=full","pubTime":"2024-05-02 10:44","pubTimestamp":1714617846,"startTime":"0","endTime":"0","summary":"5月2日，诺诚健华(09969)盘中上涨5.4%，截至10:44，报4.88元/股，成交128.97万元。诺诚健华医药有限公司是一家拥有一体化生物医药平台的领先企业，主要从事研发治疗癌症和自身免疫性疾病的创新药物。公司具备强大的内部研发能力和世界级管理团队，同时拥有均衡的管线组合和针对经过验证或新颖生物通路的候选药物。截至2023年年报，诺诚健华营业总收入7.39亿元、净利润-6.31亿元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/05/02104440509067.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2431307500","title":"太平洋：给予诺诚健华买入评级，目标价位16.1元","url":"https://stock-news.laohu8.com/highlight/detail?id=2431307500","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2431307500?lang=zh_cn&edition=full","pubTime":"2024-04-29 13:02","pubTimestamp":1714366953,"startTime":"0","endTime":"0","summary":"太平洋证券股份有限公司周豫,霍亮,戎晓婕近期对诺诚健华进行研究并发布了研究报告《血液瘤先发优势稳固，自免管线收获期临近》，本报告对诺诚健华给出买入评级，认为其目标价位为16.10元，当前股价为8.45元，预期上涨幅度为90.53%。我们分别使用DCF法和NPV法进行估值并取二者的平均数，测算出目标市值为283.73亿元人民币，对应股价为16.10元。首次覆盖给予“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291304268b604f4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404291304268b604f4c&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430033637","title":"诺诚健华：北京诺诚健华医药科技有限公司科学技术协会成立，推动科技进步","url":"https://stock-news.laohu8.com/highlight/detail?id=2430033637","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2430033637?lang=zh_cn&edition=full","pubTime":"2024-04-28 09:51","pubTimestamp":1714269105,"startTime":"0","endTime":"0","summary":"【2024年4月27日，北京诺诚健华医药科技有限公司科学技术协会正式挂牌成立，旨在推进科技创新与产学研深度融合。】 在昌平区科学技术协会的引领下，诺诚健华科学技术协会正式成立。诺诚健华旨在通过科技创新，推动产业链各环节形成合力，共同进步。诺诚健华，作为一家商业化阶段的生物医药高科技公司，专注于恶性肿瘤及自身免疫性疾病领域的一类新药研制。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404281002158b5c403a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404281002158b5c403a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430440195","title":"诺诚健华ICP-248新药亮相：奥布替尼获北京市专利一等奖","url":"https://stock-news.laohu8.com/highlight/detail?id=2430440195","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2430440195?lang=zh_cn&edition=full","pubTime":"2024-04-25 18:01","pubTimestamp":1714039305,"startTime":"0","endTime":"0","summary":" 诺诚健华携其最新研发成果亮相4月25日至29日在北京举办的2024中关村论坛年会，并参与多个论坛和闭门会。在国际技术交易大会上，该公司首次公开展示了其自主研发的新型口服高选择性BCL2抑制剂ICP-248。奥布替尼作为国家“重大新药创制”专项成果，已在中国和新加坡获批上市，并在中国获批三项适应症，纳入中国国家医保。4月25日，在中关村论坛全球知识产权保护与创新论坛上，奥布替尼核心专利荣获第七届北京市发明专利奖一等奖。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251934138b52dc45&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251934138b52dc45&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430427644","title":"诺诚健华连续亮相中关村论坛，高质量创新赋能新质生产力发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2430427644","media":"证券时报网","top":-1,"share":"https://www.laohu8.com/m/news/2430427644?lang=zh_cn&edition=full","pubTime":"2024-04-25 16:15","pubTimestamp":1714032900,"startTime":"0","endTime":"0","summary":"北京诺诚健华医药科技有限公司科学技术协会将在4月27日举办的中关村“留学人员创新创业”平行论坛上举行揭牌仪式，旨在构建完善的创新生态，持续推动科技进步。ICP-248是诺诚健华自主研发的新型口服高选择性BCL2抑制剂，首次亮相中关村论坛，参与国际技术交易大会“新技术新产品首发与推介大会”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042516154387ae3b80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042516154387ae3b80&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2430422547","title":"诺诚健华-U04月25日主力资金流出36万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2430422547","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2430422547?lang=zh_cn&edition=full","pubTime":"2024-04-25 15:19","pubTimestamp":1714029552,"startTime":"0","endTime":"0","summary":"04月25日, 诺诚健华-U股价跌0.25%，报收8.14元，成交金额2300万元，换手率1.10%，振幅2.45%，量比0.93。诺诚健华-U今日主力资金净流出36万元，连续3日净流出，上一交易日主力净流出696万元，今日环比减少94.83%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为43.48%，平均跌幅为1.52%。该股近5个交易日上涨3.17%，主力资金累计净流出624万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出6268万元，其中净流出天数为17日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251535148b51f1f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404251535148b51f1f6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429618730","title":"南向资金4月22日净买入诺诚健华132.10万股 连续7日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2429618730","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429618730?lang=zh_cn&edition=full","pubTime":"2024-04-23 09:31","pubTimestamp":1713835875,"startTime":"0","endTime":"0","summary":"4月22日, 南向资金增持诺诚健华132.10万股，连续7日增持。截止当日收盘，港股通共持有诺诚健华22325.89万股，占流通股12.65%。诺诚健华近5个交易日下跌11.02%，港股通累计增持539.80万股；近20个交易日下跌13.04%，港股通累计增持958.00万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042309475987a38983&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024042309475987a38983&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428063331","title":"诺诚健华：公司的研发与经营截至目前一切正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2428063331","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2428063331?lang=zh_cn&edition=full","pubTime":"2024-04-19 16:36","pubTimestamp":1713515814,"startTime":"0","endTime":"0","summary":"每经AI快讯，有投资者在投资者互动平台提问：尊敬的董秘，您好！近期诺诚健华股价A股持续下跌，大幅破发。请问公司是出现了什么问题吗？希望能通过回购等措施保护投资者权益，这既可以维护公司形象，给投资人信心，也有利于行业持续发展。谢谢！诺诚健华（688428.SH）4月19日在投资者互动平台表示，公司的研发与经营截至目前一切正常。二级市场受多种因素影响，请注意投资风险。文章来源：每日经济新闻原标题：诺诚健华：公司的研发与经营截至目前一切正常","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191649218b3a4224&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404191649218b3a4224&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428508948","title":"诺诚健华盘中异动 大幅下跌5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428508948","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428508948?lang=zh_cn&edition=full","pubTime":"2024-04-19 11:03","pubTimestamp":1713495812,"startTime":"0","endTime":"0","summary":"2024年04月19日早盘11时03分，诺诚健华股票出现异动，股价急速下挫5.10%。截至发稿，该股报4.090港元/股，成交量152.694万股，换手率0.10%，振幅4.87%。诺诚健华股票所在的生物技术行业中，整体跌幅为1.22%。其相关个股中，创胜集团-B、三叶草生物-B、帝王国际投资涨幅较大，振幅较大的相关个股有三叶草生物-B、创胜集团-B、乐普生物-B，振幅分别为12.70%、12.50%、9.30%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041911033287e820a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041911033287e820a1&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427811876","title":"诺诚健华-U04月16日主力资金流出114万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2427811876","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427811876?lang=zh_cn&edition=full","pubTime":"2024-04-16 15:19","pubTimestamp":1713251947,"startTime":"0","endTime":"0","summary":"04月16日, 诺诚健华-U股价跌3.87%，报收7.71元，成交金额3389万元，换手率1.69%，振幅4.61%，量比1.18。诺诚健华-U今日主力资金净流出114万元，连续5日净流出，上一交易日主力净流出748万元，今日环比减少84.76%。近一年数据显示，该股主力连续5日净流出后，次日下跌概率为75.00%，平均跌幅为1.25%。该股近5个交易日下跌14.24%，主力资金累计净流出1923万元；近20日主力资金累计净流出5742万元，其中净流出天数为17日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161538158b296fb8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161538158b296fb8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427010045","title":"诺诚健华-U大幅下跌 券商给予增持买入建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2427010045","media":"智选洞察","top":-1,"share":"https://www.laohu8.com/m/news/2427010045?lang=zh_cn&edition=full","pubTime":"2024-04-15 13:14","pubTimestamp":1713158087,"startTime":"0","endTime":"0","summary":"04月15日，诺诚健华-U股价大幅下跌，截至13点14分，诺诚健华-U下跌5.00%，报7.98元/股，创近2月新低，成交3082万元，换手率1.47%，振幅6.43%。此外，数据统计显示，近半年内1家券商给予增持建议，2家券商给予买入建议。资金动向截止发稿，诺诚健华-U获得主力净流出565万元，其中超大单流出444万元，大单流出120万元。主营业务及业绩诺诚健华-U公司主营业务为诺诚健华医药有限公司是一家主要从事生物医药的研发、生产和商业化的中国公司。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041513145679207e66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041513145679207e66&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426725922","title":"诺诚健华-U04月12日主力资金流出254万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2426725922","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2426725922?lang=zh_cn&edition=full","pubTime":"2024-04-12 15:19","pubTimestamp":1712906365,"startTime":"0","endTime":"0","summary":"04月12日, 诺诚健华-U股价跌2.10%，报收8.40元，成交金额2779万元，换手率1.27%，振幅3.26%，量比1.16。诺诚健华-U今日主力资金净流出254万元，连续3日净流出，上一交易日主力净流出342万元，今日环比减少25.73%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为41.67%，平均跌幅为1.10%。该股近5个交易日下跌6.87%，主力资金累计净流出1346万元；近20日主力资金累计净流出3955万元，其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412154028876d680f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240412154028876d680f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425062370","title":"诺诚健华盘中异动 早盘股价大跌5.11%报4.640港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2425062370","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425062370?lang=zh_cn&edition=full","pubTime":"2024-04-05 10:01","pubTimestamp":1712282474,"startTime":"0","endTime":"0","summary":"2024年04月05日早盘10时01分，诺诚健华股票出现异动，股价急速跳水5.11%。截至发稿，该股报4.640港元/股，成交量17.3万股，换手率0.01%，振幅5.32%。资金方面，该股资金流入13.634万港元，流出51.935万港元。诺诚健华股票所在的生物技术行业中，整体跌幅为1.19%。该信息摘要如下：近日， 诺诚健华 发布2023年年度报告。去年，诺诚健华的整体业绩良好，其自主研发的首款商业化拳头产品奥布替尼可谓功不可没。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405100115791ed36a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240405100115791ed36a&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2425377441","title":"南向资金4月3日净买入诺诚健华15.10万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2425377441","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2425377441?lang=zh_cn&edition=full","pubTime":"2024-04-05 09:30","pubTimestamp":1712280624,"startTime":"0","endTime":"0","summary":"4月3日, 南向资金增持诺诚健华15.10万股，连续3日增持。截止当日收盘，港股通共持有诺诚健华21904.49万股，占流通股12.42%。港股通增持金额前五个股分别为腾讯控股、小米集团-W、工商银行、中国银行、理想汽车-W。诺诚健华近5个交易日上涨1.24%，港股通累计增持170.10万股；近20个交易日下跌5.23%，港股通累计增持744.60万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404050932568af288a7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404050932568af288a7&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424869746","title":"诺诚健华-U04月03日主力资金流出568万元 连续7日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2424869746","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424869746?lang=zh_cn&edition=full","pubTime":"2024-04-03 15:18","pubTimestamp":1712128722,"startTime":"0","endTime":"0","summary":"04月03日, 诺诚健华-U股价跌1.31%，报收9.02元，成交金额2622万元，换手率1.13%，振幅2.30%，量比1.03。诺诚健华-U今日主力资金净流出568万元，连续7日净流出，上一交易日主力净流出1389万元，今日环比减少59.11%。近一年数据显示，该股主力连续7日净流出后，次日下跌概率为66.67%，平均跌幅为3.28%。该股近5个交易日下跌2.06%，主力资金累计净流出2593万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出3644万元，其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404031530478aec52c6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404031530478aec52c6&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2424889318","title":"寻找医药新质生产力：从诺诚健华（9969.HK/688428.SH）看本土创新药企高质量发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2424889318","media":"格隆汇","top":-1,"share":"https://www.laohu8.com/m/news/2424889318?lang=zh_cn&edition=full","pubTime":"2024-04-03 08:27","pubTimestamp":1712104040,"startTime":"0","endTime":"0","summary":"诺诚健华作为本土创新药企的代表，可谓成为高质量发展的优质样本。","market":"us","thumbnail":"https://img2.gelonghui.com/aaa26-063bf2a0-83fb-4931-b0a7-358d85f90af8.jpg?guru_height=2160&guru_width=3840","type":0,"news_type":0,"thumbnails":["https://img2.gelonghui.com/aaa26-063bf2a0-83fb-4931-b0a7-358d85f90af8.jpg?guru_height=2160&guru_width=3840"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/715588","is_publish_highlight":false,"gpt_icon":0},{"id":"2424058221","title":"诺诚健华盘中异动 下午盘急速上涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2424058221","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2424058221?lang=zh_cn&edition=full","pubTime":"2024-04-02 13:07","pubTimestamp":1712034468,"startTime":"0","endTime":"0","summary":"2024年04月02日下午盘13时07分，诺诚健华股票出现异动，股价快速上涨5.38%。截至发稿，该股报4.901港元/股，成交量133.899万股，换手率0.09%，振幅4.73%。诺诚健华股票所在的生物技术行业中，整体跌幅为0.35%。该信息摘要如下：据证券之星公开数据整理，近期诺诚健华发布2023年年报。根据财报显示，本报告期中诺诚健华营收上升亏损收窄，盈利能力上升。截至本报告期末，公司营业总收入7.39亿元，同比上升18.09%，归母净利润-6.31亿元，同比上升28.8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402130748861e2e97&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240402130748861e2e97&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2022-09-21","address":"OgierGlobal(Cayman)Limited,89NexusWay,CamanaBay,GrandCayman,KY1-9009,CaymanIslands","stockEarnings":[{"period":"1week","weight":0.0893},{"period":"1month","weight":-0.0903},{"period":"3month","weight":-0.0668},{"period":"6month","weight":-0.1981},{"period":"1year","weight":-0.3474},{"period":"ytd","weight":-0.247}],"companyName":"诺诚健华医药有限公司","boardCode":"AI0027","perCapita":"--","boardName":"医药制造业","registeredCapital":"0万元","compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":0.0209},{"period":"3month","weight":0.1134},{"period":"6month","weight":0.0317},{"period":"1year","weight":-0.0657},{"period":"ytd","weight":0.0437}],"survey":"　　诺诚健华医药有限公司的主营业务为创新药的研发、生产及商业化。主要产品为奥布替尼、ICP-192、ICP-723、ICP-332、ICP-189、ICP-490、Tafasitamab、ICP-105、ICP-033、ICP-488、ICP-248、ICP-B03、ICP-915、ICP-B02等。公司获得奖项为中国技术创业协会科技创新贡献奖、北京市“专精特新”中小企业、中国新经济企业500强等。","serverTime":1714880243798,"listedPrice":11.03,"stockholders":"0人","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"诺诚健华(688428)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供诺诚健华(688428)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"诺诚健华,688428,诺诚健华股票,诺诚健华股票老虎,诺诚健华股票老虎国际,诺诚健华行情,诺诚健华股票行情,诺诚健华股价,诺诚健华股市,诺诚健华股票价格,诺诚健华股票交易,诺诚健华股票购买,诺诚健华股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"诺诚健华(688428)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供诺诚健华(688428)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}